Academic Clinical Oncology, Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.
Department of Pathology, Queen's Medical Centre, Nottingham University Hospital, Nottingham, NG7 2UH, UK.
J Cancer Res Clin Oncol. 2019 Apr;145(4):909-919. doi: 10.1007/s00432-019-02856-9. Epub 2019 Feb 8.
We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calpains. Microtubule-associated protein 4 (MAP4) has been reported to be regulated by Syk.
The current study assessed Syk and MAP4 protein expression, by immunohistochemistry on a tissue microarray comprised of cores from primary ovarian carcinomas (n = 575), to evaluate associations with patient clinical outcomes and other clinicopathological factors and sought to determine whether there were any correlations between the expression of Syk, MAP4 and the calpain system.
MAP4 expression was significantly associated with ovarian cancer histological subtype (P < 0.001), stage (P = 0.001), grade (P < 0.001) and residual tumour (P = 0.005). Despite this finding, we found no significant association existing between MAP4 expression and overall survival. Syk expression was also found significantly associated with histological subtype (P < 0.001). Syk seems to play a contradictory role with respect to tumour progression: low cytoplasmic Syk expression was significantly associated with low stage (P = 0.013), and low nuclear Syk expression with chemo-resistance in patients treated with taxane-containing therapy (P = 0.006). Interestingly, despite the lack of association in the whole cohort, high nuclear Syk expression was significantly associated with better overall survival in certain subgroups (P = 0.001).
The current study indicates a lack of correlation between calpain-2 expression and Syk and MAP4. Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. Overall, the current results suggest that Syk, MAP4, and calpain-1 expression are correlated with each other and these proteins may be involved in early stages of tumour spread.
我们之前曾报道过钙蛋白酶家族蛋白在卵巢癌中的预后重要性,尤其是钙蛋白酶-2。脾酪氨酸激酶(Syk)磷酸化多种细胞骨架蛋白,研究表明 Syk 与传统钙蛋白酶之间存在潜在相互作用。微管相关蛋白 4(MAP4)已被报道受 Syk 调控。
本研究通过对包含原发性卵巢癌核心的组织微阵列进行免疫组织化学评估,检测 Syk 和 MAP4 蛋白的表达,以评估与患者临床结局和其他临床病理因素的相关性,并试图确定 Syk、MAP4 和钙蛋白酶系统之间是否存在任何相关性。
MAP4 表达与卵巢癌组织学亚型(P<0.001)、分期(P=0.001)、分级(P<0.001)和残留肿瘤(P=0.005)显著相关。尽管有此发现,但我们发现 MAP4 表达与总生存之间没有显著相关性。Syk 表达也与组织学亚型显著相关(P<0.001)。Syk 似乎在肿瘤进展方面起着矛盾的作用:低细胞质 Syk 表达与低分期显著相关(P=0.013),低核 Syk 表达与接受紫杉烷类药物治疗的患者的化疗耐药相关(P=0.006)。有趣的是,尽管在整个队列中没有相关性,但高核 Syk 表达与某些亚组的总生存显著相关(P=0.001)。
本研究表明钙蛋白酶-2 表达与 Syk 和 MAP4 之间缺乏相关性。Syk、MAP4 和钙蛋白酶-1 在整个队列中彼此之间似乎显著相关,在黏液性癌中,钙蛋白酶-1 与 MAP4 和 Syk 的相关性更高。总的来说,目前的结果表明,Syk、MAP4 和钙蛋白酶-1 的表达相互关联,这些蛋白可能参与肿瘤扩散的早期阶段。